#stem cell transplant

Potential cure strategy builds on unexpected findings about hematopoietic stem cells.

Ruxolitinib might have contributed to a functional cure after a stem cell transplant without a rare mutation.

A new case raises questions about the keys to success for a functional cure after a stem cell transplant.

Marc Franke is part of an exclusive circle of people cured of HIV after a stem cell transplant.

HIV-positive people who use checkpoint inhibitors have side effects, response rates and survival comparable to those of HIV-negative people.

Marc Franke is part of an exclusive circle of people cured of HIV after a stem cell transplant to treat cancer.

Gene therapy that alters CCR5 receptors and excises HIV from infected cells eliminated the virus in mice.

Finding no evidence of replication-competent HIV after many years, a German man’s doctors finally announced that he’s cured.

This may help expand the pool of available stem cells for curing HIV in people who require transplants for other medical conditions.

The Düsseldorf Patient received his transplant in 2013, but his doctors were cautious about declaring a cure.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

A new case may provide clues to help researchers develop strategies for a functional cure.

While the risky procedure is not suitable for most people living with HIV, it offers clues for more feasible approaches.

Immunocompromised people ages 12 and older are also eligible for an additional shot.

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

The latest Campbell Foundation research grant will help a UCLA scientist study HIV’s ability to mutate during CAR-T gene therapy.